Traws Operating Cycle from 2010 to 2026

TRAW Stock   2.79  0.37  15.29%   
Traws Pharma Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle is likely to outpace its year average in 2026. During the period from 2010 to 2026, Traws Pharma Operating Cycle regression line of quarterly data had mean square error of  680,200 and geometric mean of  76.14. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
2.6 K
Current Value
2.7 K
Quarterly Volatility
K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Traws Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Traws Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.3 K, Interest Expense of 1.7 K or Selling General Administrative of 8.7 M, as well as many indicators such as Price To Sales Ratio of 60.27, Dividend Yield of 0.0 or Days Sales Outstanding of 2.7 K. Traws financial statements analysis is a perfect complement when working with Traws Pharma Valuation or Volatility modules.
  
Build AI portfolio with Traws Stock
Check out the analysis of Traws Pharma Correlation against competitors.
For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.

Latest Traws Pharma's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Traws Pharma over the last few years. It is Traws Pharma's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Traws Pharma's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Traws Operating Cycle Regression Statistics

Arithmetic Mean518.17
Geometric Mean76.14
Coefficient Of Variation201.54
Mean Deviation771.21
Median58.46
Standard Deviation1,044
Sample Variance1.1M
Range2.8K
R-Value0.64
Mean Square Error680,200
R-Squared0.42
Significance0.01
Slope133.27
Total Sum of Squares17.4M

Traws Operating Cycle History

2026 2693.77
2025 2565.5
2024 2850.55
2023 29.07
2022 46.84
2021 45.22
2020 58.46

About Traws Pharma Financial Statements

Traws Pharma investors use historical fundamental indicators, such as Traws Pharma's Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Traws Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle2.6 K2.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Traws Stock Analysis

When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.